Bellevue Life Sciences Acquisition - Warrants (09/02/2028) Long Term Debt

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) (BLACW) currently reports a long-term debt of $280K as of March 2026. That compares with $280K in the prior-year period — up 0.6% year over year. Use the charts on this page to explore Bellevue Life Sciences Acquisition - Warrants (09/02/2028)'s long-term debt history and peer comparisons.

Bellevue Life Sciences Acquisition - Warrants (09/02/2028)'s long-term debt increased from $280K to $280K — a 0.6% year-over-year increase (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellevue Life Sciences Acquisition - Warrants (09/02/2028) reported $280K in long-term debt as of March 2026. That compares with $280K in the prior-year period — up 0.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $280K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellevue Life Sciences Acquisition - Warrants (09/02/2028), and consider following BLACW for alerts when major investors trade the stock.